The life sciences field in Luxembourg has constantly been developing over the past years. To keep the momentum and strengthen the sector further, we scout for international companies that might find it interesting to locate activities here and stimulate partnerships and collaborations among companies and research organisations.

In 2016, we developed a strategic approach to attract new life sciences companies to Luxembourg.

We carried out the first prospection trips to the East Coast of the United States, which resulted in meetings with 49 companies and investors. Thirty prospects are interested in getting to know more about Luxembourg. Nine potential investors expressed an interest in visiting the country, and a first investor has already been here. The Luxembourg BioHealth Cluster also discussed a possible cooperation with the NewYorkBio cluster.

We identified interesting contacts in the US for several cluster members.

We could thus provide several cluster members with leads that can help them develop their activity in North America.

Several collaborations between cluster members were initiated during the year.

We identified cooperation opportunities and facilitated contacts between members as well as between Luxembourg and international organisations, and concrete projects are currently under discussion.

Following the publication of the new European Patient Data Regulation, we worked with cluster members and others to develop a position statement about how to implement the regulation in Luxembourg so as to meet the needs of the sector in the best way possible and create potential opportunities for Luxembourg.

On the European level, in February 2016 the Manager of the BioHealth Cluster was elected president of the Council of European BioRegions (CEBR), and network of biotechnology support professionals.